Ian Keyzor
Fieldhouse Lane
Marlow, ENG SL71HZ, United Kingdom
Marlow, ENG SL71HZ, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapies for late-onset Pompe disease: a network meta-analysis utilizing patient-level and aggregate data.
Journal: Journal of comparative effectiveness research
Published: September 17, 2024
A multi-country time and motion study to describe the experience and burden associated with the treatment of Fabry disease with enzyme replacement therapy with agalsidase alfa and agalsidase beta.
Journal: Orphanet journal of rare diseases
Published: February 28, 2024
Minimal clinically important differences in six-minute walking distance in late-onset Pompe disease.
Minimal clinically important differences in six-minute walking distance in late-onset Pompe disease.
Journal: Orphanet journal of rare diseases
Published: October 05, 2023
Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS®) physical function questionnaire in late-onset Pompe disease using PROPEL phase 3 data.
Journal: Journal of patient-reported outcomes
Published: August 21, 2023
Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to Reclassification.
Journal: Biomolecules
Published: June 20, 2023
Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK.
Journal: Journal of medical economics
Published: October 04, 2019
Systematic Review of Societal Cost of Illness Evidence in Patients With Psoriatic Arthritis.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Systematic Review of Societal Cost of Illness Evidence in Patients With Ankylosing Spondylitis.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use.
Journal: Applied health economics and health policy
Published: March 27, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026